Abstract
Differential scanning calorimetry and thermogravimetric analysis with the support of X-ray powder diffraction and infrared spectroscopy were used as screening techniques for the compatibility testing of imatinib mesylate, with following excipients: magnesium stearate, polyvinylpyrrolidone, microcrystalline cellulose. In order to maximize the probability of interactions 1:1 (by mass) drug: excipient binary mixtures were analysed and compared to individual components. Additionally an influence of storage at temperatures of 25 and 40°C on physico-chemical stability on drug – excipient binary mixtures was investigated.
The largest visible changes were observed in the DSC curves of imatinib mesylate – magnesium stearate mixtures.
Similar content being viewed by others
References
GC Ceschel R Badiello C Ronchi P Maffei (2003) J. Pharm. Biomed. Anal. 32 1067-1072 Occurrence Handle12899995 Occurrence Handle10.1016/S0731-7085(03)00210-3 Occurrence Handle1:CAS:528:DC%2BD3sXlvFyhu7o%3D
VA Drebushchak TP Shakhtshneider SA Apenina AS Medvedeva LP Safronova VV Boldyrev (2006) J. Therm. Anal. Cal. 86 303 Occurrence Handle10.1007/s10973-005-7440-y Occurrence Handle1:CAS:528:DC%2BD28XhtVygs7fJ
G Giron C Goldbronn (1997) J. Thermal Anal. 48 473 Occurrence Handle10.1007/BF01979494 Occurrence Handle1:CAS:528:DyaK2sXisVyhtbY%3D
S Airaksinen et al. (2005) ‘Role of Excipients in Moisture Sorption and Physical Stability of Solid Pharmaceutical Formulations’, Academic Dissertation University of Helsinki, Faculty of Pharmacy, Division of Pharmaceutical Technology Helsinki
M Tomassetti A Catalani V Rossi S Vecchio (2005) J. Pharm. Biomed. Anal. 37 949 Occurrence Handle15862672 Occurrence Handle10.1016/j.jpba.2004.10.008 Occurrence Handle1:CAS:528:DC%2BD2MXjs1Klsrk%3D
P Mura GP Bettinetti MT Faucci A Manderioli PL Parrini (1998) Thermochim. Acta 321 59 Occurrence Handle10.1016/S0040-6031(98)00440-7 Occurrence Handle1:CAS:528:DyaK1cXmvVyqtb8%3D
‘Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use’, J. Zimmermann, B. Sutter and H. M. Bürger, Filing date: 16.07.98, WO 99/03854.
Y. Kitamura, S. Hirota, T. Nishida, Cancer Sci., Vol. 94. p. 315.
M V Chandu de Silva R Reid (2003) Pathol. Oncol. Res. 9 13 Occurrence Handle12704441 Occurrence Handle1:CAS:528:DC%2BD3sXmtFamt7c%3D Occurrence Handle10.1007/BF03033708
K. Korczak, A. Pietraszko, M. Gawryś, H. Beczkowicz, W. J. Szczepek, D. Samson-Łazińska and B. Zagrodzki, Eds, 45th Polish Crystallographic Meeting, The book of abstracts, p. 91.
‘Process for preparation of imatinib monomesylate crystalline form α’, W. Szczepek, D. Łazińska, R. Modzelewski, U. Frączek, M. Ławecka, B. Zagrodzki, M. Glice, W. Maruszak, K. Korczak, P. Cmoch, Ł. Kaczmarek and W. Szelejewski, Eds, Filing date: 2.04.2005, PCT/PL05/000024.
GGG Oliveira HG Ferraz JSR Matos (2005) J. Therm. Anal. Cal. 79 267 Occurrence Handle10.1007/s10973-005-0047-5 Occurrence Handle1:CAS:528:DC%2BD2MXkt1Ciu70%3D
F Balestrieri AD Magri AL Margi D Marini A Sacchini (1996) Thermochim. Acta 285 337 Occurrence Handle10.1016/0040-6031(96)02904-8 Occurrence Handle1:CAS:528:DyaK28XmtVyrurk%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Łaszcz, M., Kosmacińska, B., Korczak, K. et al. tudy on compatibility of imatinib mesylate with pharmaceutical excipients. J Therm Anal Calorim 88, 305–310 (2007). https://doi.org/10.1007/s10973-006-8001-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-006-8001-8